Phase 2 Systemic Inflammatory Response Syndrome Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
Systemic Inflammatory Response Syndrome
Hospital General Universitario Gregorio Marañon24 enrolled1 locationNCT06052436
Recruiting
Phase 2
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
SepsisPathologic ProcessesInfections+4 more
Ottawa Hospital Research Institute296 enrolled2 locationsNCT05969275
Completed
Phase 2Phase 3
Vitamin D dosing study in Intensive Care Unit patients
Systemic Inflammatory Response Syndrome
Dr Priya Nair50 enrolled1 locationACTRN12618000217202